LAVA Therapeutics N.V.

NASDAQ:LVTX

1.32 (USD) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -25.114-41.695-31.658-51.232-15.927-10.991
Depreciation & Amortization 0.4670.6120.7810.6330.4580.294
Deferred Income Tax -0.01-0.279-0.249-0.178-0.0530
Stock Based Compensation 3.2265.0394.1134.4290.5570.218
Change In Working Capital 4.383-3.87634.11312.2864.730.705
Accounts Receivables 01.589-2.70.774-1.3090.037
Inventory 0000-0.520
Accounts Payables -1.5690.3521.4131.8340.347-0.216
Other Working Capital 5.952-5.81732.710.4527.190.883
Other Non Cash Items -2.496-0.488-3.0571.1431.066-0.192
Operating Cash Flow -19.544-38.9724.043-32.477-9.307-9.775
Investing Activities:
Investments In Property Plant And Equipment -0.023-0.73-0.587-0.866-0.659-0.865
Acquisitions Net 000000
Purchases Of Investments -97.09-90.082-70.877-51.3470-0.034
Sales Maturities Of Investments 109.573.17780.812.84600
Other Investing Activites 0.08809.276-42.6130-0.029
Investing Cash Flow 12.475-17.6359.346-49.367-0.502-0.899
Financing Activities:
Debt Repayment -0.596-0.5710.2680.341.7931.176
Common Stock Issued 00094.18900
Common Stock Repurchased 0000-6.1530
Dividends Paid 000000
Other Financing Activities 000.01556.63117.1760
Financing Cash Flow -0.569-0.5710.283171.37218.9691.334
Other Information:
Effect Of Forex Changes On Cash -1.5781.076-4.208-4.441-0.68-0.491
Net Change In Cash -9.216-56.1029.46485.0868.48-9.83
Cash At End Of Period 35.01544.231100.333103.01915.8188.326